<?xml version="1.0" encoding="UTF-8"?>
<!-- Generated on Sun, 22 Nov 2026 12:14:17 -0500 -->
<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>    <title>PharmaCyte Biotech, Inc. (PMCB) News</title>
    <link>https://ir.pharmacyte.com/annual-reports/rss</link>
    <description>PharmaCyte Biotech, Inc. (PMCB) - Annual Reports</description>
    <language>en-us</language>
    <generator>Equisolve Investor Relations Suite</generator>
    <image>
      <url>http://content.stockpr.com/pharmacytebiotech/files/PharmaCyteBiotech-logo.png</url>
      <title></title>
      <link>https://www.pharmacyte.com</link>
      <width></width>
      <height></height>
    </image>
    <item>
      <title><![CDATA[ SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership ]]></title>
      <description><![CDATA[ SCHEDULE 13D/A ]]></description>
      <link>https://ir.pharmacyte.com/annual-reports?page=1#document-2893-0001683168-26-009020</link>
      <pubDate>Fri, 20 Nov 26 20:32:14 -0500</pubDate>
      <guid isPermaLink="true">https://ir.pharmacyte.com/annual-reports?page=1#document-2893-0001683168-26-009020</guid>
    </item>
    <item>
      <title><![CDATA[ 4 - Statement of changes in beneficial ownership of securities ]]></title>
      <description><![CDATA[ 4 ]]></description>
      <link>https://ir.pharmacyte.com/annual-reports?page=1#document-2892-0001683168-26-009018</link>
      <pubDate>Fri, 20 Nov 26 20:30:35 -0500</pubDate>
      <guid isPermaLink="true">https://ir.pharmacyte.com/annual-reports?page=1#document-2892-0001683168-26-009018</guid>
    </item>
    <item>
      <title><![CDATA[ 8-K - Current report ]]></title>
      <description><![CDATA[ 2 Related Documents:<br />8-K, EX-10.1 ]]></description>
      <link>https://ir.pharmacyte.com/annual-reports?page=1#document-2891-0001683168-26-008964</link>
      <pubDate>Thu, 19 Nov 26 17:00:58 -0500</pubDate>
      <guid isPermaLink="true">https://ir.pharmacyte.com/annual-reports?page=1#document-2891-0001683168-26-008964</guid>
    </item>
    <item>
      <title><![CDATA[ 8-K - Current report ]]></title>
      <description><![CDATA[ 3 Related Documents:<br />8-K, EX-3.1, EX-99.1 ]]></description>
      <link>https://ir.pharmacyte.com/annual-reports?page=1#document-2889-0001683168-26-008705</link>
      <pubDate>Fri, 13 Nov 26 16:29:01 -0500</pubDate>
      <guid isPermaLink="true">https://ir.pharmacyte.com/annual-reports?page=1#document-2889-0001683168-26-008705</guid>
    </item>
    <item>
      <title><![CDATA[ 8-K - Current report ]]></title>
      <description><![CDATA[ 2 Related Documents:<br />8-K, EX-16.1 ]]></description>
      <link>https://ir.pharmacyte.com/annual-reports?page=1#document-2886-0001683168-26-007934</link>
      <pubDate>Fri, 16 Oct 26 17:01:02 -0400</pubDate>
      <guid isPermaLink="true">https://ir.pharmacyte.com/annual-reports?page=1#document-2886-0001683168-26-007934</guid>
    </item>
    <item>
      <title><![CDATA[ 10-Q - Quarterly report [Sections 13 or 15(d)] ]]></title>
      <description><![CDATA[ 5 Related Documents:<br />10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2 ]]></description>
      <link>https://ir.pharmacyte.com/annual-reports?page=1#document-2884-0001683168-26-007106</link>
      <pubDate>Mon, 14 Sep 26 16:07:34 -0400</pubDate>
      <guid isPermaLink="true">https://ir.pharmacyte.com/annual-reports?page=1#document-2884-0001683168-26-007106</guid>
    </item>
    <item>
      <title><![CDATA[ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] ]]></title>
      <description><![CDATA[ 8 Related Documents:<br />10-K, EX-3.6, EX-21.1, EX-23.1, EX-31.1, EX-31.2, EX-32.1, EX-32.2 ]]></description>
      <link>https://ir.pharmacyte.com/annual-reports?page=1#document-2879-0001683168-26-005836</link>
      <pubDate>Wed, 29 Jul 26 16:59:33 -0400</pubDate>
      <guid isPermaLink="true">https://ir.pharmacyte.com/annual-reports?page=1#document-2879-0001683168-26-005836</guid>
    </item>
    <item>
      <title><![CDATA[ 4/A - Statement of changes in beneficial ownership of securities ]]></title>
      <description><![CDATA[ 4/A ]]></description>
      <link>https://ir.pharmacyte.com/annual-reports?page=1#document-2871-0001683168-26-005619</link>
      <pubDate>Fri, 17 Jul 26 17:00:53 -0400</pubDate>
      <guid isPermaLink="true">https://ir.pharmacyte.com/annual-reports?page=1#document-2871-0001683168-26-005619</guid>
    </item>
    <item>
      <title><![CDATA[ 4/A - Statement of changes in beneficial ownership of securities ]]></title>
      <description><![CDATA[ 4/A ]]></description>
      <link>https://ir.pharmacyte.com/annual-reports?page=1#document-2870-0001683168-26-005620</link>
      <pubDate>Fri, 17 Jul 26 17:00:48 -0400</pubDate>
      <guid isPermaLink="true">https://ir.pharmacyte.com/annual-reports?page=1#document-2870-0001683168-26-005620</guid>
    </item>
    <item>
      <title><![CDATA[ 4/A - Statement of changes in beneficial ownership of securities ]]></title>
      <description><![CDATA[ 4/A ]]></description>
      <link>https://ir.pharmacyte.com/annual-reports?page=1#document-2869-0001683168-26-005621</link>
      <pubDate>Fri, 17 Jul 26 17:00:43 -0400</pubDate>
      <guid isPermaLink="true">https://ir.pharmacyte.com/annual-reports?page=1#document-2869-0001683168-26-005621</guid>
    </item>
    <item>
      <title><![CDATA[ 4/A - Statement of changes in beneficial ownership of securities ]]></title>
      <description><![CDATA[ 4/A ]]></description>
      <link>https://ir.pharmacyte.com/annual-reports?page=2#document-2868-0001683168-26-005622</link>
      <pubDate>Fri, 17 Jul 26 17:00:38 -0400</pubDate>
      <guid isPermaLink="true">https://ir.pharmacyte.com/annual-reports?page=2#document-2868-0001683168-26-005622</guid>
    </item>
    <item>
      <title><![CDATA[ 4 - Statement of changes in beneficial ownership of securities ]]></title>
      <description><![CDATA[ 2 Related Documents:<br />4, EX-24.1 ]]></description>
      <link>https://ir.pharmacyte.com/annual-reports?page=2#document-2858-0001683168-26-002630</link>
      <pubDate>Thu, 02 Apr 26 18:17:15 -0400</pubDate>
      <guid isPermaLink="true">https://ir.pharmacyte.com/annual-reports?page=2#document-2858-0001683168-26-002630</guid>
    </item>
    <item>
      <title><![CDATA[ 8-K - Current report ]]></title>
      <description><![CDATA[ 2 Related Documents:<br />8-K, EX-10.1 ]]></description>
      <link>https://ir.pharmacyte.com/annual-reports?page=2#document-2856-0001683168-26-002613</link>
      <pubDate>Thu, 02 Apr 26 16:20:22 -0400</pubDate>
      <guid isPermaLink="true">https://ir.pharmacyte.com/annual-reports?page=2#document-2856-0001683168-26-002613</guid>
    </item>
    <item>
      <title><![CDATA[ 4 - Statement of changes in beneficial ownership of securities ]]></title>
      <description><![CDATA[ 4 ]]></description>
      <link>https://ir.pharmacyte.com/annual-reports?page=2#document-2859-0001683168-26-002631</link>
      <pubDate>Thu, 02 Apr 26 18:17:30 -0400</pubDate>
      <guid isPermaLink="true">https://ir.pharmacyte.com/annual-reports?page=2#document-2859-0001683168-26-002631</guid>
    </item>
    <item>
      <title><![CDATA[ 4 - Statement of changes in beneficial ownership of securities ]]></title>
      <description><![CDATA[ 4 ]]></description>
      <link>https://ir.pharmacyte.com/annual-reports?page=2#document-2860-0001683168-26-002632</link>
      <pubDate>Thu, 02 Apr 26 18:17:51 -0400</pubDate>
      <guid isPermaLink="true">https://ir.pharmacyte.com/annual-reports?page=2#document-2860-0001683168-26-002632</guid>
    </item>
    <item>
      <title><![CDATA[ 4 - Statement of changes in beneficial ownership of securities ]]></title>
      <description><![CDATA[ 4 ]]></description>
      <link>https://ir.pharmacyte.com/annual-reports?page=2#document-2861-0001683168-26-002633</link>
      <pubDate>Thu, 02 Apr 26 18:17:56 -0400</pubDate>
      <guid isPermaLink="true">https://ir.pharmacyte.com/annual-reports?page=2#document-2861-0001683168-26-002633</guid>
    </item>
    <item>
      <title><![CDATA[ 4 - Statement of changes in beneficial ownership of securities ]]></title>
      <description><![CDATA[ 4 ]]></description>
      <link>https://ir.pharmacyte.com/annual-reports?page=2#document-2854-0001683168-26-001989</link>
      <pubDate>Wed, 18 Mar 26 17:08:28 -0400</pubDate>
      <guid isPermaLink="true">https://ir.pharmacyte.com/annual-reports?page=2#document-2854-0001683168-26-001989</guid>
    </item>
    <item>
      <title><![CDATA[ SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors ]]></title>
      <description><![CDATA[ SCHEDULE 13G ]]></description>
      <link>https://ir.pharmacyte.com/annual-reports?page=2#document-2863-0001683168-26-001988</link>
      <pubDate>Tue, 14 Apr 26 12:28:56 -0400</pubDate>
      <guid isPermaLink="true">https://ir.pharmacyte.com/annual-reports?page=2#document-2863-0001683168-26-001988</guid>
    </item>
    <item>
      <title><![CDATA[ 10-Q - Quarterly report [Sections 13 or 15(d)] ]]></title>
      <description><![CDATA[ 5 Related Documents:<br />10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2 ]]></description>
      <link>https://ir.pharmacyte.com/annual-reports?page=2#document-2852-0001683168-26-001917</link>
      <pubDate>Tue, 17 Mar 26 15:50:35 -0400</pubDate>
      <guid isPermaLink="true">https://ir.pharmacyte.com/annual-reports?page=2#document-2852-0001683168-26-001917</guid>
    </item>
    <item>
      <title><![CDATA[ DEF 14A - Definitive proxy statements ]]></title>
      <description><![CDATA[ DEF 14A ]]></description>
      <link>https://ir.pharmacyte.com/annual-reports?page=2#document-2846-0001683168-26-001593</link>
      <pubDate>Mon, 09 Mar 26 06:03:56 -0400</pubDate>
      <guid isPermaLink="true">https://ir.pharmacyte.com/annual-reports?page=2#document-2846-0001683168-26-001593</guid>
    </item>
  </channel></rss>